Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-10-08Clinical Trial Update: Postoperative Pain and Angiotensin II Receptor Antagonists [Phase 4]
Clinical trial update for a Phase 4 study evaluating angiotensin II receptor antagonists in hypertension; the current trial status is unknow…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas [NA]
This clinical trial update reports on a brief intervention to improve medication knowledge and adherence among family medicine patients in S…
-
CLINICAL_TRIALS research · 2015-10-08Clinical Trial Update: Impact of Energy Drinks and Panax Ginseng on Heart Rhythm [NA]
Clinical trial update evaluating the impact of energy drinks and Panax ginseng on heart rhythm. The study also notes potential effects on bl…
-
FDA approval · 2015-10-07FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approves a supplemental application for Losartan Potassium by Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Insights for Community Health [NA]
A clinical trial conducted by NYU Langone Health focusing on hypertension has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-10-02FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) from Waylis Therapeutics LLC, approving the controlled-release f…
-
FDA approval · 2015-10-02FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2015-10-02FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for amlodipine besylate as a generic product under an ANDA, expanding its availabilit…
-
FDA approval · 2015-10-02FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for a nifedipine product from Leading Pharma, LLC, associated with an approved generic (ANDA074045).
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation
This clinical trial update reports short- and long-term results on arterial stiffness and central aortic pressure in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation [Phase 1]
This is an update on a Phase 1 pilot study evaluating gastric sleeve surgery in morbidly obese patients undergoing liver transplantation; th…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Improving Prevention of Heart Disease in Latinos
A completed clinical trial update from the University of Colorado, Denver reports results from a study aimed at improving prevention of hear…
-
CLINICAL_TRIALS research · 2015-10-01Clinical Trial Update: Association of Dipping Pattern or Early Morning Surge of BP With Asymptomatic Episodes of Paroxysmal Atrial Fibrillation in Subjects With Hypertension (DIMOSPAF)
This clinical trial update discusses whether dipping pattern or early morning surge in blood pressure is associated with asymptomatic episod…
-
CLINICAL_TRIALS other · 2015-09-30Clinical Trial Update: The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese [Phase 2, Phase 3]
A clinical trial update indicates Phase 2 and Phase 3 studies are evaluating the effects of nifedipine and metoprolol on blood pressure vari…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension [Phase 2]
A Phase 2 study evaluated potential drug-drug interaction between Entresto (sacubitril/valsartan) and sildenafil in adults with hypertension…
-
FDA approval · 2015-09-25FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate by PD-Rx Pharmaceuticals, Inc. under ANDA 076719, allowing marketing of this…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton [Phase 1]
Phase 1 pharmacokinetic study comparing the fixed-dose combination YH22162 with a separate telmisartan/amlodipine plus chlorthalidone regime…
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Influence of Aliskiren on Proteinuria [Phase 4]
Phase 4 trial update assessing the influence of aliskiren on proteinuria in patients with chronic kidney disease and hypertension.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure [Phase 4]
This Clinical Trial Update reports on a Phase 4 study sponsored by Chong Kun Dang Pharmaceutical evaluating the efficacy and safety of a tre…
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Meta-analyses of Dietary Pulses and Cardiometabolic Risk
A meta-analysis update examining how dietary pulses relate to cardiometabolic risk factors, summarizing potential effects on lipid, glucose,…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI [Phase 2]
This Phase 2 trial compares redo pulmonary vein isolation for recurrent atrial fibrillation after an initial PVI, with and without renal den…
-
FDA approval · 2015-09-18FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for amlodipine besylate (generic amlodipine) under an ANDA, allowing the update…
-
FDA approval · 2015-09-18FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application to add a 2.5 mg strength of amlodipine besylate for Oxford Pharmaceuticals’ generic product, expandi…
-
FDA approval · 2015-09-17FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for AMLODIPINE BESYLATE from Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS) [Phase 4]
Phase 4 clinical trial evaluating febuxostat's effects on blood pressure and the intrarenal renin-angiotensin system; results were posted af…